Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2011 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: The Dodgy Ticker who wrote (29)	12/31/2010 1:59:10 PM
From: keokalani'nui	Read Replies (4) \| Respond to of 400

$150 to winner, $50 to thread host. Huge congrats to rkrw and rocky. My picks: ABT 15% AMLN 15% ARIA 10% BMY 15% BLRX.TA 10% HALO 10% MNTA 10% ZIOP 15% If ABT or BMY are objectionable because of their BP properties, I will gladly substitute. The reasons I picked them however, are based on a biotech bets. I think ABT is really cheap due to perceived risks to Humira from pfe's jak. I'm betting that particular fear eases this year. I picked BMY because I think they have one of the best pipelines, particularly ipilimumab and apixaban. Bulba, I await and defer to your wisdom. A safe, warm and rewarding new year to all.